Hi folks.  This week a landmark gene therapy to treat blindness got one step closer to FDA approval with a resounding panel endorsement.  And the FDA issued a disappointing CRL for an acute pain medication.  Here are the top regulatory news stories for pharma and biotech this week: Flexion Therapeutics secured approval from the US[…]